NLS Pharmaceutics AG Statistics
Total Valuation
NLSP has a market cap or net worth of $5.24 million. The enterprise value is $3.59 million.
| Market Cap | 5.24M |
| Enterprise Value | 3.59M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NLSP has 39.56 million shares outstanding. The number of shares has increased by 244.88% in one year.
| Shares Outstanding | 39.56M |
| Shares Change (YoY) | +244.88% |
| Shares Change (QoQ) | +93.96% |
| Owned by Insiders (%) | 31.54% |
| Owned by Institutions (%) | 23.84% |
| Float | 19.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58
| Current Ratio | 0.58 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -167.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -714.70% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.58M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.87% in the last 52 weeks. The beta is -0.84, so NLSP's price volatility has been lower than the market average.
| Beta (1Y) | -0.84 |
| 52-Week Price Change | -90.87% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.57 |
| Relative Strength Index (RSI) | 28.71 |
| Average Volume (30 Days) | 587,591 |
Short Selling Information
The latest short interest is 75,112, so 0.19% of the outstanding shares have been sold short.
| Short Interest | 75,112 |
| Short Previous Month | 335,801 |
| Short % of Shares Out | 0.19% |
| Short % of Float | 0.38% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.34M |
| Pretax Income | -15.47M |
| Net Income | -15.47M |
| EBITDA | -15.36M |
| EBIT | -15.38M |
| Earnings Per Share (EPS) | -$0.50 |
Balance Sheet
The company has $1.65 million in cash and no debt, giving a net cash position of $1.65 million or $0.04 per share.
| Cash & Cash Equivalents | 1.65M |
| Total Debt | n/a |
| Net Cash | 1.65M |
| Net Cash Per Share | $0.04 |
| Equity / Book Value | -4.29M |
| Book Value Per Share | -0.11 |
| Working Capital | -1.65M |
Cash Flow
| Operating Cash Flow | -13.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | -13.51M |
| FCF Per Share | -$0.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NLSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -244.88% |
| Shareholder Yield | -244.88% |
| Earnings Yield | -295.29% |
| FCF Yield | -257.92% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |